Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, Joshua D. Palmer, Raju R. Raval, Shirley Ong, Pierre Giglio, M. Hassan Murad, Vinay K. Puduvalli
Abstract
[This corrects the article DOI: 10.1093/noajnl/vdaa082.].
Topics & Concepts
TemozolomideGlioblastomaCancer researchMedicineOncologyComputational biologyChemistryBiologyGlioma Diagnosis and TreatmentBrain Metastases and TreatmentHistone Deacetylase Inhibitors Research